Dodd Heres Ltd/Cannapharma is a global leader in the extraction and isolation of both major and minor cannabinoids, having already developed proprietary manufacturing processes for CBD-HQ synthesis and providing a range of standard CBD-based products including oils, jellies and topicals.
Smart is Innovate UK’s responsive grant funding programme. Innovate UK, part of UK Research and Innovation, invests up to £25 million in the best game-changing, and world leading ideas, designed for swift, successful commercialisation.
Dodd Heres’ project will scale up their CBD-HQ synthesis to a commercially viable level of 90% CBD to CBD-HQ, in just 12 hours. The innovation combines known chemical components and synthesis techniques with their proprietary reactor to form a totally new process that will revolutionise CBD-HQ production.
Catax worked with Dodd Heres to secure an Innovate UK Smart grant of £500,000.
“The team at Catax has guided us through this application with confidence and proficiency. Laura and Kiran were exceptional and kept the process professional and well structured, with concise actions and communication. We are delighted with the depth of their knowledge, both on the application process and understanding of our industry.
“As a result, Dodd Heres will be the first UK cannabis company to receive grant funding from Innovate UK, with £500,000 earmarked for developing our proprietary cannabidiol synthesis technology. We will be using the Catax team for all our future grant applications.”
If you’d like information on how we can support your business with innovation funding, please fill in the enquiry form below: